ENDRA Life Sciences
NDRA
5 hedge funds and large institutions have $824K invested in ENDRA Life Sciences in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
46% less capital invested
Capital invested by funds: $1.53M → $824K (-$705K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
ICM Asset Management
Spokane,
Washington
|
+$278K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$92.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WEC
Winslow Evans & Crocker
Boston,
Massachusetts
|
-$34K |
| 2 |
VWM
Vigilare Wealth Management
Scottsdale,
Arizona
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IAM
1
ICM Asset Management
Spokane,
Washington
| $633K | +$278K | +6 | +32% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $71K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $46K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $38K | +$92.7K | +2 | New |
|
|
BRWA
5
B. Riley Wealth Advisors
Boca Raton,
Florida
| $17K | – | – | – |
|
6
Northern Trust
Chicago,
Illinois
| $11K | – | – | – |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $2K | – | – | – |
|
9
Victory Capital Management
San Antonio,
Texas
| $2K | – | – | – |
|
10
Morgan Stanley
New York
| $1K | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
WEC
12
Winslow Evans & Crocker
Boston,
Massachusetts
| – | -$34K | -1 | Closed |
|
|
VWM
13
Vigilare Wealth Management
Scottsdale,
Arizona
| – | -$15K | – | – |
|
NDRA Hedge Fund Activity: Q1 2020 in Review
5 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2020, worth a combined $824K — down 46% from $1.53M a quarter earlier.
Fund positioning in NDRA was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was ICM Asset Management, adding an estimated $278K. The largest seller was Winslow Evans & Crocker, exiting entirely with an estimated $34K sold.
- 5 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $824K of ENDRA Life Sciences stock for Q1 2020, down 46% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences positions in Q1 2020 and 1 closed out, a net change of 0 holders.
- The largest ENDRA Life Sciences buyer in Q1 2020 was ICM Asset Management, an estimated $278K added.
- The largest ENDRA Life Sciences seller in Q1 2020 was Winslow Evans & Crocker, an estimated $34K sold.
Based on aggregated 13F filings for Q1 2020.